Table 1.

Participants demographics and clinical data.

	Patients (n = 21)	Controls (n = 24)
Age	39.19 (24–58; SD 8.99)	39.7 (24–58; SD 9.71)	t-test, p= 0.854
Gender	19M 2F	10M 14F
Education (Years)	9.25 (SD 1.48)	16.4 (SD 4.54)	t-test, p< 0.01
Illness duration (years)	19.9 (SD 10.74)	–
PANSS-P	14.90 (SD 6.78)	–
PANSS-N	20.61 (SD 6.41)	–
PANSS-GP	33.61 (SD 8.09)	–
CPZ equivalent dose*	638.189 (SD 408.28)	–

Mean and SD, standard deviation.

*Chlorpromazine equivalent dose (mg/day).